CJC-1295 No DAC / Ipamorelin (5mg/5mg Activated - 2.5mg/2.5mg/mL - 2mL)

CJC-1295 No DAC / Ipamorelin — 5mg/5mg Activated | 2.5mg/2.5mg/mL — 2mL

Combined research peptide blend pre-reconstituted at 2.5mg/2.5mg per mL in a 2mL vial. CJC-1295 (No DAC / Modified GRF 1-29) and Ipamorelin are both studied in growth hormone secretion and GHRH/GHS-R1a receptor pathway research.

• CJC-1295 (No DAC): 5mg total (2.5mg/mL) — synthetic GHRH analog studied in GHRH receptor pathways
• Ipamorelin: 5mg total (2.5mg/mL) — selective synthetic pentapeptide GHRP studied in GHS-R1a receptor pathways
• Volume: 2mL
• Form: Activated (pre-reconstituted)
• Purity: ≥98% per peptide (HPLC verified)
• Storage: Refrigerate at 2–8°C, protect from light

Multi-dose format ready for laboratory research protocols.

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION, INGESTION, INJECTION, OR ANY IN-VIVO DIAGNOSTIC OR THERAPEUTIC USE. NOT A DRUG, FOOD, COSMETIC, OR DIETARY SUPPLEMENT.

Manufacturing & Quality: Produced under pharmaceutical-grade manufacturing standards with third-party lab verification and batch-specific Certificates of Analysis (COA) available on request. For laboratory research use only — not for human consumption.